Variables affecting outcome in critically ill patients

被引:20
作者
Chernow, B [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
关键词
D O I
10.1378/chest.115.suppl_2.71S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Critical care medicine has evolved as a field of science and clinical care. Despite important contributions to our understanding of the molecular basis of critical illness, we still remain troubled by our lack of insight into why some patients have favorable outcomes from critical illness and others do not, This article explores the hypothesis that at least five important variables may alter the outcome of patients suffering from a variety, of critical illnesses. These variables include the premorbid immune or genetic status of the patient, the patient's gender, the circulating cholesterol concentration, the patient's age, and various iatrogenic and nosocomial events, Insights into the importance of these five variables may provide opportunities for physicians and scientists to improve outcome in patients suffering from critical illness, Clearly, altering iatrogenic and nosocomial events is already within the realm of opportunity.
引用
收藏
页码:71S / 76S
页数:6
相关论文
共 70 条
  • [1] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
    Abraham, E
    Glauser, MP
    Butler, T
    Garbino, J
    Gelmont, D
    Laterre, PF
    Kudsk, K
    Bruining, HA
    Otto, C
    Tobin, E
    Zwingelstein, C
    Lesslauer, W
    Leighton, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
  • [2] Chemokines: Leucocyte recruitment and activation cytokines
    Adams, DH
    Lloyd, AR
    [J]. LANCET, 1997, 349 (9050) : 490 - 495
  • [3] Testosterone and/or low estradiol: Normally required but harmful immunologically for males after trauma-hemorrhage
    Angele, MK
    Ayala, A
    Monfils, BA
    Cioffi, WG
    Bland, KI
    Chaudry, IH
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1998, 44 (01) : 78 - 84
  • [4] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [5] β-blocker dosages and mortality after myocardial infarction -: Data from a large health maintenance organization
    Barron, HV
    Viskin, S
    Lundstrom, RJ
    Swain, BE
    Truman, AF
    Wong, CC
    Selby, JV
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (05) : 449 - 453
  • [6] The costs of adverse drug events in hospitalized patients
    Bates, DW
    Spell, N
    Cullen, DJ
    Burdick, E
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Leape, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 307 - 311
  • [7] Trauma patients 75 years and older: Long-term follow-up results justify aggressive management
    Battistella, FD
    Din, AM
    Perez, L
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1998, 44 (04): : 618 - 623
  • [8] An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
    Beg, AA
    Baltimore, D
    [J]. SCIENCE, 1996, 274 (5288) : 782 - 784
  • [9] Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects
    BenJonathan, N
    Mershon, JL
    Allen, DL
    Steinmetz, RW
    [J]. ENDOCRINE REVIEWS, 1996, 17 (06) : 639 - 669
  • [10] BennettGuerrero E, 1997, JAMA-J AM MED ASSOC, V277, P646